Updated:
Altamont Pharmaceutical Holdings
Altamont Pharmaceutical Holdings is a Dallas-based private equity asset manager.
Altamont Pharmaceutical Holdings
Altamont leverages its network and internal expertise to analyze data to identify high growth opportunities that generate outperforming returns. After making an investment, Altamont assists its portfolio companies in pursuing their market growth opportunities and product research and development by working closely with founders and management to build value. Altamont’s portfolio spans a wide range of therapeutic areas and products. We leverage our network of renowned PhDs, MD Researchers, and Practitioners to support optimization of clinical development programs of our portfolio companies. Altamont is a biotech investment firm focusing on investments in undervalued small to mid-cap, publicly traded biotech companies, incubating startup companies by licensing promising technologies from world-renowned research institutes and universities, as well as partnering with large pharma companies around the world. Altamont’s philosophy is to invest long-term in the vision of the entrepreneurs and scientists striving to cure life threatening diseases and reduce the effects of chronic disease.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Dallas
Corporate office
Dallas, United States
Frequently asked questions
What is Altamont Pharmaceutical Holdings?
Altamont Pharmaceutical Holdings is a private equity headquartered in Dallas, United States.
Where is Altamont Pharmaceutical Holdings headquartered?
Altamont Pharmaceutical Holdings is headquartered in Dallas, United States, in the North America region.
What is Altamont Pharmaceutical Holdings's assets under management?
Altamont Pharmaceutical Holdings reports approximately Undisclosed in assets under management, as tracked by Altss.
What does Altss track for Altamont Pharmaceutical Holdings?
Altss maintains an OSINT-verified profile of Altamont Pharmaceutical Holdings covering investment focus (ESG policy, ticket size, target IRR, currency preference, regional focuses, industry focuses, technological focuses), team (service providers and advisors), deals (company deals and fund commitments), and network (associations and event participation). Detailed values are available to Altss subscribers.
What is Altamont Pharmaceutical Holdings's website?
Altamont Pharmaceutical Holdings's public website is altamontpharma.com. Verified contact details for principals and decision-makers are available to Altss subscribers.
What type of firm is Altamont Pharmaceutical Holdings?
Altamont Pharmaceutical Holdings is classified by Altss as a Private Equity, operating from United States within the North America region.
How does Altss source intelligence on Altamont Pharmaceutical Holdings?
Altss combines OSINT (open-source intelligence) with regulatory filings, public disclosures, and licensed data partners. Source provenance is tracked to support compliance-ready research workflows.
When was Altamont Pharmaceutical Holdings's Altss profile last updated?
Altamont Pharmaceutical Holdings's profile on Altss was last refreshed on May 29, 2026. Continuous updates are applied as new public information is verified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: